Constitutive and induced expression of APO-1, a new member of the nerve growth factor/tumor necrosis factor receptor superfamily, in normal and neoplastic cells.
Frank Leithäuser, Peter Möller(University of Copenhagen), Gunhild Mechtersheimer(Heidelberg University), Jens Dhein(German Cancer Research Center), Klaus‐Michael Debatin(German Centre for Cardiovascular Research), Peter H. Krammer(Slovak Academy of Sciences), K Koretz(Heidelberg University), Silke Brüderlein(Heidelberg University), C. Henne(Heidelberg University), Annemarie Schmidt(Heidelberg University)
PubMed
October 1, 1993
Cited by 637
Related Papers
Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018
|Cell Death and Differentiation|2018|6.6k
FLICE, A Novel FADD-Homologous ICE/CED-3–like Protease, Is Recruited to the CD95 (Fas/APO-1) Death-Inducing Signaling Complex
|Cell|1996|3.1k
Cytotoxicity‐dependent APO‐1 (Fas/CD95)‐associated proteins form a death‐inducing signaling complex (DISC) with the receptor.
|The EMBO Journal|1995|2.2k
Death and anti-death: tumour resistance to apoptosis
|Nature reviews. Cancer|2002|2.1k
Monoclonal Antibody-Mediated Tumor Regression by Induction of Apoptosis
|Science|1989|1.7k